A new pancreatic adenocarcinoma‐derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms-Reference-Cited by-同舟云学术

A new pancreatic adenocarcinoma‐derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms

Published:2021-10-16 Issue:1 Volume:114 Page:32-55
ISSN:0248-4900
Container-title:Biology of the Cell
language:en
Short-container-title:Biology of the Cell

Author:

Hadj Bachir Elsa¹,Poiraud Charles¹²,Paget Sonia¹,Stoup Nicolas¹,El Moghrabi Soumaya¹,Duchêne Belinda¹,Jouy Nathalie³,Bongiovanni Antonino³,Tardivel Meryem³,Weiswald Louis‐Bastien⁴⁵,Vandepeutte Marie¹,Beugniez César¹²,Escande Fabienne⁶,Leteurtre Emmanuelle¹⁷,Poulain Laurent⁴⁵,Lagadec Chann¹,Pigny Pascal¹,Jonckheere Nicolas¹,Renaud Florence¹⁷,Truant Stephanie¹²,Van Seuningen Isabelle¹,Vincent Audrey¹,

Affiliation:

1. CNRS, Inserm, CHU Lille, UMR9020‐U1277 ‐ CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies Univ. Lille Lille France

2. Department of Digestive Surgery and Transplantation CHU Lille Lille France

3. UMS 2014 – US 41 – PLBS – Plateformes Lilloises en Biologie & Santé BioImaging Center Lille (BICeL) Univ. Lille Lille France

4. UNICAEN Inserm U1086 ANTICIPE “Interdisciplinary Research Unit for Cancer Prevention and Treatment” Normandie Univ Caen France

5. Cancer Centre F. Baclesse UNICANCER Caen France

6. Department of Biochemistry and Molecular Biology CHU Lille Hormonology Metabolism Nutrition Oncology Lille France

7. Department of Pathology CHU Lille Univ. Lille Lille France

Funder

Centre hospitalier régional universitaire de Lille

Fondation ARC pour la Recherche sur le Cancer

Institut National Du Cancer

Région Hauts-de-France

Université de Lille

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/boc.202100003

Reference67 articles.

1. In vitro activation of irinotecan to SN‐38 by human liver and intestine;Ahmed F.;Anticancer Research,1999

2. Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis

3. LGR5 and Nanog identify stem cell signature of pancreas beta cells which initiate pancreatic cancer

4. Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses

5. Modeling Pancreatic Cancer with Organoids

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11

2. The tumor microenvironment in therapy resistance;Frontiers in Lab on a Chip Technologies;2024-09-10

3. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology;Experimental & Molecular Medicine;2024-07-01

4. Establishment and Advancement of Pancreatic Organoids;Keimyung Medical Journal;2024-06-15

5. Abstract 232: Multi-dimensional patient-derived organoid analysis highly correlates with progression-free survival of pancreatic cancer patients in a retrospective clinical trial;Cancer Research;2024-03-22